TPP2 and neoplasm: Studies using extended versions of peptide epitopes have revealed that TPPII can contribute to trimming of their N-terminals, as shown for the H-2Kb-restricted ovalbumin epitope SIINFEKL and RU-1, a renal carcinoma tumour antigen [50, 51].